Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 5
2009 2
2010 4
2011 3
2012 5
2013 1
2014 1
2015 2
2016 4
2017 5
2018 3
2019 7
2020 6
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

50 results
Results by year
Filters applied: . Clear all
Page 1
Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib.
Brunetti O, Gnoni A, Licchetta A, Longo V, Calabrese A, Argentiero A, Delcuratolo S, Solimando AG, Casadei-Gardini A, Silvestris N. Brunetti O, et al. Among authors: longo v. Medicina (Kaunas). 2019 Oct 21;55(10):707. doi: 10.3390/medicina55100707. Medicina (Kaunas). 2019. PMID: 31640191 Free PMC article. Review.
Management of patients with end-stage renal disease undergoing chemotherapy: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Nefrologia (SIN).
Pedrazzoli P, Silvestris N, Santoro A, Secondino S, Brunetti O, Longo V, Mancini E, Mariucci S, Rampino T, Delfanti S, Brugnatelli S, Cinieri S. Pedrazzoli P, et al. Among authors: longo v. ESMO Open. 2017 Jul 19;2(3):e000167. doi: 10.1136/esmoopen-2017-000167. eCollection 2017. ESMO Open. 2017. PMID: 29209521 Free PMC article.
Immunotherapeutic approaches for hepatocellular carcinoma.
Longo V, Gnoni A, Casadei Gardini A, Pisconti S, Licchetta A, Scartozzi M, Memeo R, Palmieri VO, Aprile G, Santini D, Nardulli P, Silvestris N, Brunetti O. Longo V, et al. Oncotarget. 2017 May 16;8(20):33897-33910. doi: 10.18632/oncotarget.15406. Oncotarget. 2017. PMID: 28420805 Free PMC article. Review.
Innovative surgical approaches for hepatocellular carcinoma.
Memeo R, de'Angelis N, de Blasi V, Cherkaoui Z, Brunetti O, Longo V, Piardi T, Sommacale D, Marescaux J, Mutter D, Pessaux P. Memeo R, et al. Among authors: longo v. World J Hepatol. 2016 May 8;8(13):591-6. doi: 10.4254/wjh.v8.i13.591. World J Hepatol. 2016. PMID: 27168871 Free PMC article. Review.
BRMS1 expression in resected lung adenocarcinoma.
Galetta D, Pizzutilo P, Longo V. Galetta D, et al. Among authors: longo v. Transl Lung Cancer Res. 2018 Dec;7(Suppl 4):S364-S366. doi: 10.21037/tlcr.2018.09.20. Transl Lung Cancer Res. 2018. PMID: 30705857 Free PMC article. No abstract available.
Immune system and bone microenvironment: rationale for targeted cancer therapies.
Gnoni A, Brunetti O, Longo V, Calabrese A, Argentiero AL, Calbi R, Solimando Antonio G, Licchetta A. Gnoni A, et al. Among authors: longo v. Oncotarget. 2020 Jan 28;11(4):480-487. doi: 10.18632/oncotarget.27439. eCollection 2020 Jan 28. Oncotarget. 2020. PMID: 32064051 Free PMC article. Review.
Mast cells and angiogenesis in pancreatic ductal adenocarcinoma.
Longo V, Tamma R, Brunetti O, Pisconti S, Argentiero A, Silvestris N, Ribatti D. Longo V, et al. Clin Exp Med. 2018 Aug;18(3):319-323. doi: 10.1007/s10238-018-0493-6. Epub 2018 Feb 28. Clin Exp Med. 2018. PMID: 29492715 Review.
Neoadjuvant multimodal treatment of pancreatic ductal adenocarcinoma.
Silvestris N, Longo V, Cellini F, Reni M, Bittoni A, Cataldo I, Partelli S, Falconi M, Scarpa A, Brunetti O, Lorusso V, Santini D, Morganti A, Valentini V, Cascinu S. Silvestris N, et al. Among authors: longo v. Crit Rev Oncol Hematol. 2016 Feb;98:309-24. doi: 10.1016/j.critrevonc.2015.11.016. Epub 2015 Nov 23. Crit Rev Oncol Hematol. 2016. PMID: 26653573 Review.
50 results